Currently, the group is focusing on designing and developing clinical trials for malignant genitourinary tumours with the active participation of researchers in the Urology, Radiotherapy and Medical Oncology departments.

They are advancing in their research with the help of platforms created to form alliances, such as the urology cancer translational research platform, or the  creation of a translational platform for basic research and sarcomas in close collaboration with the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL - Bellvitge Biomedical Research Institute) and the Centro de Investigación del Cáncer (CIC - Cancer Research Centre) in Salamanca. Also within the institute they are expanding the translational research platform for glioblastoma in collaboration with the Vall d'Hebron Institute of Oncology Gene Expression and Cancer group.

Visit the research group’s page


Subscribe to our newsletters and be a part of Vall d'Hebron Campus

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.